Skip to main content
CRDF
NASDAQ Life Sciences

Cardiff Posts $30.4M Nine-Month Loss; Phase 3 Slips to Q1 2027 Pending Financing

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.77
Mkt Cap
$59.537M
52W Low
$0.75
52W High
$3.31
52W Position info
2.6% above low
Off High info
77% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CRDF is trading near its 52-week low of $0.75 (2.6% above the low).

Summary

Cardiff reported a $30.4M net loss for the nine months ended September 30, 2026, narrower than the $38.6M loss a year earlier, with operating expenses down to $32.0M from $41.5M as R&D activity slowed ahead of the planned registrational study. For the third quarter, revenue was $171,000 and the loss was $8.86M. Cash stood at $33.8M, which management says funds operations through Q3 2027 — but the Phase 3 start, now targeted for Q1 2027, is explicitly contingent on raising additional money. The Phase 2 update is immature: median PFS in the 30 mg onvansertib arm was not reached versus roughly 11 months in the combined standard-of-care arms. The financing caveat is the crux for a company trading near its 52-week low with a going-concern warning in the last 10-Q; shareholders recently approved doubling authorized shares to 300 million, giving room to raise. Watch for a capital raise, which is the gating item before the Phase 3 trial can begin.

At the time of this announcement, CRDF was trading at $0.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $59.5M. The 52-week trading range was $0.75 to $3.31. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CRDF - Latest Insights

CRDF
Nov 12, 2026, 4:21 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7276
Real-time Price: $0.740 info
Change: +$0.0124 (+2%) info
Market Cap: $56.604M info
CRDF
Nov 12, 2026, 4:20 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7276
Real-time Price: $0.740 info
Change: +$0.0124 (+2%) info
Market Cap: $56.604M info
CRDF
Oct 27, 2026, 4:44 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8988
Real-time Price: $0.740 info
Change: -$0.1588 (-18%) info
Market Cap: $56.604M info
CRDF
Oct 21, 2026, 6:09 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.740 info
Change: -$0.210 (-22%) info
Market Cap: $56.604M info
CRDF
Sep 14, 2026, 9:28 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.24
Real-time Price: $0.740 info
Change: -$0.4981 (-40%) info
Market Cap: $56.604M info